Advancing In Vivo CAR-T with QSP
Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…
CertaraMay 12, 2026
Certara IQ™ Demo
Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…
CertaraMay 12, 2026
Best Practices for pharma commercialization in market access
Learn best practices for your pharma commercialization strategy. See how to localize content in pharma…
CertaraMay 12, 2026
PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials
The FDA is shifting toward approving drugs based on a single pivotal trial supported by…
CertaraMay 12, 2026
4 Key Principles of Effective Pharmacokinetic Data Reporting
Improve pharmacokinetic data reports with clear structure, effective visuals, and strong data presentation for actionable…
CertaraMay 11, 2026
Certara Reports First Quarter 2026 Financial Results
RADNOR, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…
CertaraMay 11, 2026
Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace
See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve.
Danielle PillsburyMay 8, 2026
